Oxygenta Pharmaceutical Ltd - Related Party Transactions Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2022

With respect to the cited subject, please find the attached Disclosure of Related party transactions under Regulation 23(9) of the SEBI (LODR) Regulations, 2015 for the half year ended 30th September, 2022. Please take the same on record and acknowledge the receipt of the same. Thanking you